77
Fashion Jobs
BEIERSDORF
Sales Representative North Greece (Based in Thessaloniki)
Permanent · ATHENS
FOOT LOCKER
Συνεργάτης Πωλήσεων
Permanent · THESSALONIKI
L'OREAL GROUP
Senior Product Manager Maybelline – Consumer Products Division
Permanent · NEA IONIA
CLINIQUE
Consumer Marketing Manager, Clinique
Permanent · ATHENS
LA MER
Consumer Marketing Executive, LA Mer
Permanent · ATHENS
TOM FORD
Consumer Marketing Manager Tom Ford
Permanent · ATHENS
L'OREAL GROUP
Beauty Advisor
Permanent · THESSALONIKI
L'OREAL GROUP
Nyx pm Beauty Advisor (Attiki)
Permanent · ATHENS
H&M
Σύμβουλος Πωλήσεων - Μερική Απασχόληση
Permanent · CHALANDRI
ESTÉE LAUDER COMPANIES
Fixed Assets & Decorations Supervisor
Permanent · ATHENS
SEPHORA
Accounting
Permanent · ATHENS
SEPHORA
Category Specialist
Permanent · ATHENS
H&M
Σύμβουλος Πωλήσεων (Mare West) - Μερική Απασχόληση
Permanent ·
H&M
Σύμβουλος Πωλήσεων - Μερική Απασχόληση
Permanent · PIRAEUS
H&M
Hiring Day Chania - Sales Advisors
Permanent · CHANIA
MAD LORDS
Sales Assistant Scorpios Mykonos
Fixed-term · MYKONOS
FOOT LOCKER
Συνεργάτης Πωλήσεων
Permanent · MAROUSI
FOOT LOCKER
Συνεργάτης Πωλήσεων
Permanent · ATHENS
H&M
Σύμβουλος Πωλήσεων (Metro Mall) - Μερική Απασχόληση
Permanent · AGIOS DIMITRIOS
H&M
Σύμβουλος Πωλήσεων - Μερική Απασχόληση
Permanent · KALAMATA
H&M
Σύμβουλος Πωλήσεων - Μερική Απασχόληση
Permanent · NEA IONIA
GUESS
Sales Advisor (Greece)
Permanent · ATHENS
By
Reuters
Published
Mar 31, 2009
Download
Download the article
Print
Text size

Ipsen wins anti-wrinkle drug go-ahead in France

By
Reuters
Published
Mar 31, 2009

PARIS, March 31 (Reuters) - French drugmaker Ipsen (IPN.PA) and its partner Galderma have won French marketing approval for anti-wrinkle treatment Azzalure, a rival to Allergan's (AGN.N) Botox.


Ipsen Pharmaceutical Laboratory

Ipsen shares rose 2.5 percent to 28.70 euros by 0753 GMT.

Galderma is a joint venture between Swiss food maker Nestle (NESN.VX) and French cosmetics company L`Oreal (OREP.PA).

Azzalure obtained approval for the temporary improvement in the appearance of moderate to severe lines between the eyebrows in adults when the severity of these lines has an important psychological impact on the patient, Ipsen said in a statement on Tuesday.

Azzalure, an injectable botulinum toxin product that relaxes the muscles, will be marketed by dermatology company Galderma in France before the end of the first half of this year.

Ipsen's anti-wrinkle treatment, approved in more than 20 countries including Britain, is awaiting approval in the United States where it will be distributed by Medicis Pharmaceutical Corp (MRX.N) under the name Reloxin. The Food and Drug Administration is to review the drug on April 13.

© Thomson Reuters 2024 All rights reserved.